Levana.ai
AI-based Platform for Personalizing Women's Prescriptions
Company Overview
Snapshot
Founded in May 2022 by Ilana Kwartin, Alon Ben-Shoshan, and Roded Konforty, Levana.ai operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing an AI-based solution for personalized women's prescriptions.
Business overview
Levana.ai is a Health Tech & Life Sciences company developing an AI-based platform designed to personalize medication for women based on their menstrual cycles. The company's core technology provides recommendations to doctors on medication dosage and timing, serving patients and pharmaceutical companies within the digital healthcare sector. Levana.ai focuses on patient engagement and femtech, operating with a B2C business model.
Strategic signal
In June 2023, Levana.ai's AI-based solution for personalized medication was highlighted, drawing attention to the founder's personal experience as inspiration. This signals the company's commitment to addressing specific women's health needs through innovative technology, potentially attracting further interest in the growing femtech market.
Log in to access full profile ›Company Intelligence Q&A
- What is Levana.ai's primary focus?
- Levana.ai focuses on developing an AI-based platform to personalize women's prescriptions based on their menstrual cycles, providing recommendations to doctors on medication dosage and timing.
- When was Levana.ai founded?
- Levana.ai was founded in May 2022.
- Who are the co-founders of Levana.ai?
- Levana.ai was co-founded by Ilana Kwartin, Alon Ben-Shoshan, and Roded Konforty.
- What is the current stage of Levana.ai's product development?
- Levana.ai's product is currently in the Research & Development (R&D) stage, as confirmed by company data.
- What was a key highlight for Levana.ai in June 2023?
- In June 2023, Levana.ai's AI-based solution for personalized medication was featured, with its inspiration stemming from the founder's experience.